Jose J Rico-Jimenez1, Michael J Serafino1, Sebina Shrestha1, Xi Chen1, Wihan Kim1, Jessie Adame2, L Maximillan Buja3, Deborah Vela3, Brian E Applegate1, Javier A Jo4. 1. Department of Biomedical Engineering, Texas A& M University, College Station, TX, USA. 2. Autopsy and Pathology Services, Houston, TX, USA. 3. Texas Heart Institute, Houston, TX, USA. 4. Department of Biomedical Engineering, Texas A& M University, College Station, TX, USA; School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA. Electronic address: javierjo@ou.edu.
Abstract
BACKGROUND AND AIMS: Macrophages play an important role in the development and destabilization of advanced atherosclerotic plaques. Hence, the clinical imaging of macrophage content in advanced plaques could potentially aid in identifying patients most at risk of future clinical events. The lifetime of the autofluorescence emission from atherosclerotic plaques has been correlated with lipids and macrophage accumulation in ex vivo human coronary arteries, suggesting the potential of intravascular endogenous fluorescence or autofluorescence lifetime imaging (FLIM) for macrophage imaging. The aim of this study was to quantify the accuracy of the coronary intima autofluorescence lifetime to detect superficial macrophage accumulation in atherosclerotic plaques. METHODS: Endogenous FLIM imaging was performed on 80 fresh postmortem coronary segments from 23 subjects. The plaque autofluorescence lifetime at an emission spectral band of 494 ± 20.5 nm was used as a discriminatory feature to detect superficial macrophage accumulation in atherosclerotic plaques. Detection of superficial macrophage accumulation in the imaged coronary segments based on immunohistochemistry (CD68 staining) evaluation was taken as the gold standard. Receiver Operating Characteristic (ROC) curve analysis was applied to select an autofluorescence lifetime threshold value to detect superficial macrophages accumulation. RESULTS: A threshold of 6 ns in the plaque autofluorescence lifetime at the emission spectral band of 494 ± 20.5 nm was applied to detect plaque superficial macrophages accumulation, resulting in ∼91.5% accuracy. CONCLUSIONS: This study demonstrates the capability of endogenous FLIM imaging to accurately identify superficial macrophages accumulation in human atherosclerotic plaques, a key biomarker of atherosclerotic plaque vulnerability.
BACKGROUND AND AIMS: Macrophages play an important role in the development and destabilization of advanced atherosclerotic plaques. Hence, the clinical imaging of macrophage content in advanced plaques could potentially aid in identifying patients most at risk of future clinical events. The lifetime of the autofluorescence emission from atherosclerotic plaques has been correlated with lipids and macrophage accumulation in ex vivo human coronary arteries, suggesting the potential of intravascular endogenous fluorescence or autofluorescence lifetime imaging (FLIM) for macrophage imaging. The aim of this study was to quantify the accuracy of the coronary intima autofluorescence lifetime to detect superficial macrophage accumulation in atherosclerotic plaques. METHODS: Endogenous FLIM imaging was performed on 80 fresh postmortem coronary segments from 23 subjects. The plaque autofluorescence lifetime at an emission spectral band of 494 ± 20.5 nm was used as a discriminatory feature to detect superficial macrophage accumulation in atherosclerotic plaques. Detection of superficial macrophage accumulation in the imaged coronary segments based on immunohistochemistry (CD68 staining) evaluation was taken as the gold standard. Receiver Operating Characteristic (ROC) curve analysis was applied to select an autofluorescence lifetime threshold value to detect superficial macrophages accumulation. RESULTS: A threshold of 6 ns in the plaque autofluorescence lifetime at the emission spectral band of 494 ± 20.5 nm was applied to detect plaque superficial macrophages accumulation, resulting in ∼91.5% accuracy. CONCLUSIONS: This study demonstrates the capability of endogenous FLIM imaging to accurately identify superficial macrophages accumulation in humanatherosclerotic plaques, a key biomarker of atherosclerotic plaque vulnerability.
Authors: Rikin A Trivedi; Chinthake Mallawarachi; Jean-Marie U-King-Im; Martin J Graves; Jo Horsley; Martin J Goddard; Andrew Brown; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard Journal: Arterioscler Thromb Vasc Biol Date: 2006-04-20 Impact factor: 8.311
Authors: M E Kooi; V C Cappendijk; K B J M Cleutjens; A G H Kessels; P J E H M Kitslaar; M Borgers; P M Frederik; M J A P Daemen; J M A van Engelshoven Journal: Circulation Date: 2003-04-28 Impact factor: 29.690
Authors: Jennifer E Phipps; Deborah Vela; Taylor Hoyt; David L Halaney; J Jacob Mancuso; L Maximilian Buja; Reto Asmis; Thomas E Milner; Marc D Feldman Journal: JACC Cardiovasc Imaging Date: 2014-11-05
Authors: Raphaël Duivenvoorden; Jun Tang; David P Cormode; Aneta J Mieszawska; David Izquierdo-Garcia; Canturk Ozcan; Maarten J Otten; Neeha Zaidi; Mark E Lobatto; Sarian M van Rijs; Bram Priem; Emma L Kuan; Catherine Martel; Bernd Hewing; Hendrik Sager; Matthias Nahrendorf; Gwendalyn J Randolph; Erik S G Stroes; Valentin Fuster; Edward A Fisher; Zahi A Fayad; Willem J M Mulder Journal: Nat Commun Date: 2014 Impact factor: 14.919
Authors: Julien Bec; Jennifer E Phipps; Dimitris Gorpas; Dinglong Ma; Hussain Fatakdawala; Kenneth B Margulies; Jeffrey A Southard; Laura Marcu Journal: Sci Rep Date: 2017-08-21 Impact factor: 4.379
Authors: Jan Bucerius; Venkatesh Mani; Colin Moncrieff; Josef Machac; Valentin Fuster; Michael E Farkouh; Ahmed Tawakol; James H F Rudd; Zahi A Fayad Journal: Eur J Nucl Med Mol Imaging Date: 2013-11-23 Impact factor: 9.236